GE HEALTHCARE PAYS $30 MILLION TO SETTLE HEALTHCARE FRAUD WHISTLEBLOWER CASE

GE Healthcare, a global provider of medical technologies and pharmaceuticals has agreed to pay $30 million to settle a False Claims Act whistleblower case alleging the company provided false information in connection with its distribution of the radiopharmaceutical agent Myoview to the federal Medicare program. The drug is used by health care providers in cardiology to perform nuclear stress tests. The whistleblowers said that the company orchestrated a scheme in which Myoview was improperly diluted in order to maximize trhe number of doses available per vial. This lead to an increased number of patient-ready doses and inflated Medicare reimbursements. Under the settlement, the whistleblowers will receive $5,100,000 as his reward for blowing the whislte. Costs and attorneys fees will also be paid.

Posted in:
Updated:

One response to “GE HEALTHCARE PAYS $30 MILLION TO SETTLE HEALTHCARE FRAUD WHISTLEBLOWER CASE”

  1. Hi this is Jeff DeMarrais from GE. We are pleased to have reached a resolution in this long-standing case. Origins of this issue date back to 2000-2003, or more than a year before GE Healthcare acquired the manufacturers and distributors for the Myoview product.

    It is important to note that the allegations in the case predate GE’s acquisition of Amersham and as a result the company admits no wrongdoing.